 SOUTH SAN FRANCISCO, Calif., Jan. 15, 2021 PRNewswire -- Titan Pharmaceuticals, Inc. NASDAQ: TTNP today announced it has entered into a securities purchase agreement with certain accredited institutional investors to purchase approximately 9.7 million of its common stock in a... 